Yan Ji Huo Jin Tou Gu Gao

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with various conditions, including arthritis, bruises, simple backache, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children over 12 years of age, the affected area should be cleaned and dried prior to application. The pouch containing the patch should be opened, and the patch may be cut to size if desired. The protective backing should be peeled off, allowing the sticky side of the patch to be applied directly to the affected area. The patch may be applied up to three times daily, ensuring that it is removed from the skin after a maximum application time of 8 hours.

For children under 12 years of age, it is essential to consult a healthcare professional before use.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only, this product must be utilized strictly as directed. Healthcare professionals should advise patients to avoid contact with the eyes, mucous membranes, or any rashes. It is imperative that the product is not applied to broken, wounded, or damaged skin. Additionally, patients should refrain from bandaging or covering the treated area with any type of wrap, except for clothing. The use of heating pads or the application of external heat in conjunction with this product is contraindicated. Patients are also instructed to discontinue use at least one hour prior to bathing or showering and to avoid application immediately after such activities.

Patients should be advised to stop use and consult a healthcare provider if any of the following occur: rash, itching, or excessive skin irritation develops; the condition worsens or does not improve after regular use; or if symptoms persist for more than seven days or clear up and then recur within a few days.

In the event of accidental ingestion, it is crucial to seek emergency medical assistance or contact a Poison Control Center immediately.

Side Effects

Patients should be monitored for serious adverse reactions, including the development of a rash, itching, or excessive skin irritation. In such cases, it is advised to discontinue use and consult a healthcare professional. Additionally, if the condition worsens or does not improve after regular use, or if symptoms persist for more than 7 days or resolve only to recur within a few days, patients should seek medical advice.

These warnings highlight the importance of ongoing assessment during treatment to ensure patient safety and the effectiveness of the therapy.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Yan Ji Huo Jin Tou Gu Gao (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional prior to use. It is important to assess the appropriateness of treatment and dosage for this age group to ensure safety and efficacy.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare professional before use. There may be potential risks to the fetus; therefore, use during pregnancy should be approached with caution. No specific dosage modifications are provided for pregnant individuals; healthcare professionals should be consulted for guidance regarding the use of this product in this population.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during the use of this product.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous monitoring and supportive care should be maintained until the patient stabilizes or further treatment is determined.

In summary, while specific overdosage information is not available, healthcare professionals should remain vigilant and prepared to implement standard overdose management strategies in any suspected cases.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has indicated that this product may cause allergic reactions in some individuals. Reports of such events have been received voluntarily and through surveillance programs.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately. This information is vital for ensuring patient safety and prompt intervention if necessary.

Storage and Handling

The product is supplied in a zip lock bag, which should be kept tightly closed to maintain integrity. It is essential to store the patches in a cool, dry place, ensuring they are protected from direct sunlight to preserve their effectiveness.

Additional Clinical Information

The product is administered topically, with application to the affected area not exceeding three times daily. It is important to remove the patch from the skin after a maximum of eight hours of application. Clinicians should counsel patients that the product may cause allergic reactions in some individuals and emphasize the importance of keeping it out of reach of children. In the event of ingestion, patients should seek medical assistance or contact a Poison Control Center immediately. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Yan Ji Huo Jin Tou Gu Gao, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)